Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Feb 14:19:100152.
doi: 10.1016/j.jctube.2020.100152. eCollection 2020 May.

Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette-Guérin (BCG) immunotherapy

Ryan K Meyer  1 , Stephen J Williams  2   3 , Thomas Y Lee  4   5
Affiliations
Case Reports

Mycobacterium bovis infection of a femorofemoral bypass graft following intravesical Bacillus Calmette-Guérin (BCG) immunotherapy

Ryan K Meyer et al. J Clin Tuberc Other Mycobact Dis. .

Abstract

Vascular bypass graft infection with Mycobacterium bovis following Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer is an incredibly rare complication. We present the case of an 85-year-old man with a history of femorofemoral bypass who developed this complication over a year after BCG treatment. He was successfully treated with explantation of the polytetrafluoroethylene (PTFE) graft, redo bypass with vein graft, and antituberculous medical therapy.

Keywords: Bacillus Calmette–Guérin; Bladder cancer; Mycobacterium bovis; Pembrolizumab; Prosthetic bypass graft infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Computed tomography scan of the pelvis. The arrow marks the site of an open groin wound over the bypass graft.
See this image and copyright information in PMC

References

    1. Antoni S., Ferlay J., Soerjomataram I., Znaor A., Jemal A. Bladder cancer incidence and mortality: a global review and recent trends. Eur Urol. 2017;71:96–108. - PubMed
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–13. - PubMed
    1. Burger M., Catto J.W.F., Dalbagni G., Grossman H.B., Herr H. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–241. - PubMed
    1. Morales A., Eidinger D., Bruce A.W. Intracavitary bacillus Calmette–Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116(2):180–183. - PubMed
    1. Larsen E.S., Joensen U.N., Poulsen A.M., Goletti D., Johansen I.S. Bacillus Calmette–Guerin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections. APMIS. 2020 - PubMed

    2. https://onlinelibrary.wiley.com/doi/abs/10.1111/apm.13011.

Publication types

LinkOut - more resources